Prostate Cancer Survey
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/15/2019 |
| Start Date: | March 15, 2017 |
| End Date: | December 31, 2021 |
Identifying Patient-relevant Adverse Events Following Prostate Radiotherapy
There have been calls from patients, payers, healthcare providers, and policy makers for an
evaluation of newer, high-cost radiation technologies compared to conventional forms of
radiation therapy. National attention has focused on the use of intensity modulated radiation
therapy (IMRT) into routine daily clinical practice for prostate cancer. The goal of the
present study is to determine whether the type of radiation treatment received by the
patients can result in a reduction in patient-relevant side effects following prostate
irradiation. The analysis will be performed by obtaining patient answered surveys looking at
side effects.
evaluation of newer, high-cost radiation technologies compared to conventional forms of
radiation therapy. National attention has focused on the use of intensity modulated radiation
therapy (IMRT) into routine daily clinical practice for prostate cancer. The goal of the
present study is to determine whether the type of radiation treatment received by the
patients can result in a reduction in patient-relevant side effects following prostate
irradiation. The analysis will be performed by obtaining patient answered surveys looking at
side effects.
Inclusion Criteria:
- Participant is 18 years or older
- Has been diagnosed with prostate cancer
- Able to speak and read English
Exclusion Criteria:
- Participant is not being seen for prostate cancer
- Under the age of 18
We found this trial at
1
site
22 South Greene Street
Baltimore, Maryland 21201
Baltimore, Maryland 21201
Principal Investigator: Mark Mishra, MD
Phone: 410-328-7501
Click here to add this to my saved trials
